Download PDF
Dtsch Med Wochenschr 2006; 131(25/26): 1435-1437
DOI: 10.1055/s-2006-946594
Klinischer Fortschritt | Commentary

© Georg Thieme Verlag KG Stuttgart · New York

Kardiologie - Update

Cardiology - an updateU. C. Hoppe1 , E. Erdmann1
  • 1Klinik III für Innere Medizin, Universität zu Köln
Further Information

Publication History

Publication Date:
05 July 2006 (online)

Also available at
    Permissions and Reprints

Einleitung

Welches sind die bedeutendsten Forschritte der kardiovaskulären Medizin des letzten Jahres für Diagnostik und Therapie der Patienten? [9]. Einige Neuerungen haben bereits Eingang in die Behandlung genommen, andere Studienergebnisse haben leider unsere Hoffnungen nicht erfüllt. Im Folgenden werden klinisch besonders relevante aktuelle Entwicklungen und Ergebnisse dargestellt.

Literatur

  • 1 Antman E M, Morrow D A, McCabe C H. et al . Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.  N Engl J Med. 2006;  354 1477-1488
    Search in Google Scholar
  • 2 Bonaa K H, Njolstad I, Ueland P M. et al . Homocysteine lowering and cardiovascular events after acute myocardial infarction.  N Engl J Med. 2006;  354 1578-1588
    Search in Google Scholar
  • 3 Bradley T D, Logan A G, Kimoff R J. et al . Continuous positive airway pressure for central sleep apnea and heart failure.  N Engl J Med. 2005;  353 2025-2033
    Search in Google Scholar
  • 4 Cleland J G, Freemantle N, Coletta A P, Clark A L. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.  Eur J Heart Fail. 2006;  8 105-110
    Search in Google Scholar
  • 5 Dormandy J A, Charbonnel B, Eckland D J. et al . Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.  Lancet. 2005;  366 1279-1289
    Search in Google Scholar
  • 6 Flather M D, Shibata M C, Coats A J. et al . Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).  Eur Heart J. 2005;  26 215-225
    Search in Google Scholar
  • 7 Holmes D R, Teirstein P, Satler L. et al . Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.  Jama. 2006;  295 1264-1273
    Search in Google Scholar
  • 8 Hoppe U C, Böhm M, Dietz R. et al . Leitlinien zur Therapie der chronischen Herzinsuffizienz. Im Auftrag der Deutschen Gesellschaft für Kardiologie.  Z Kardiol. 2005;  94 488-509
    Search in Google Scholar
  • 9 Hoppe U C, Erdmann E. Was ist neu in der Kardiologie?.  Dtsch Med Wochenschr. 2005;  130 1540-1542
    Search in Google Scholar
  • 10 Hunt S A, Abraham W T, Chin M H. et al . ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult.  Circulation. 2005;  112 e154-235
    Search in Google Scholar
  • 11 Janssens S, Dubois C, Bogaert J. et al . Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.  Lancet. 2006;  367 113-121
    Search in Google Scholar
  • 12 Lonn E S, Yusuf M J, Arnold P. et al . Homocysteine lowering with folic acid and B vitamins in vascular disease.  N Engl J Med. 2006;  354 1567-1577
    Search in Google Scholar
  • 13 Meyer G P, Wollert K C, Lotz J. et al . Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.  Circulation. 2006;  113 1287-1294
    Search in Google Scholar
  • 14 Stone G W, Ellis S G, O’Shaughnessy C D. et al . Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.  Jama. 2006;  295 1253-1263
    Search in Google Scholar
  • 15 Swedberg K, Cleland J, Dargie H. et al . Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.  Eur Heart J. 2005;  26 1115-1140
    Search in Google Scholar
  • 16 Willenheimer R B, Israelsson B A, Cline C M, Erhardt L R. Simplified echocardiography in the diagnosis of heart failure.  Scand Cardiovasc J. 1997;  31 9-16
    Search in Google Scholar
  • 17 Yusuf S, Mehta S R, Chrolavicius S. et al . Comparison of fondaparinux and enoxaparin in acute coronary syndromes.  N Engl J Med. 2006;  354 1464-1476
    Search in Google Scholar
  • 18 Yusuf S, Mehta S R, Chrolavicius S. et al . Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.  Jama. 2006;  295 1519-1530
    Search in Google Scholar
  • 19 Zohlnhofer D, Ott I, Mehilli J. et al . Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.  Jama. 2006;  295 1003-1010
    Search in Google Scholar

Prof. Dr. med. Erland Erdmann
Prof. Dr. med. Uta C. Hoppe

Klinik III für Innere Medizin, Universität zu Köln

Kerpener Str. 62

50937 Köln